| Literature DB >> 30753364 |
Jose Diego Brito-Sousa1,2, Thalie C Santos2, Sara Avalos3, Gustavo Fontecha3, Gisely C Melo1,2, Fernando Val1,2, André M Siqueira4, Graça C Alecrim1, Quique Bassat5,6,7,8, Marcus V G Lacerda1,9, Wuelton M Monteiro1,2.
Abstract
Despite glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence of 5% in the Amazon, primaquine is administered without G6PD screening. This is an important cause of hospitalization among Plasmodium vivax-infected individuals, leading to life-threatening anemia and acute renal failure across endemic areas. In Manaus, the frequency of primaquine-induced hemolysis was 85.2 cases per 100 000 primaquine users.Entities:
Keywords: G6PD deficiency; acute renal failure; elimination; primaquine; severe anemia
Year: 2019 PMID: 30753364 DOI: 10.1093/cid/ciz122
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079